Quarterly Result5 May 2026, 03:24 pm
Ajanta Pharma FY26: Revenue Up 17%, PAT Up 15%
AI Summary
Ajanta Pharma Ltd. reported its audited consolidated financial results for the year ended March 31, 2026. The company's revenue from operations increased by 17% to ₹5,453 cr, while profit after tax (PAT) rose by 15% to ₹1,056 cr. The Board meeting was held on May 5, 2026, where the results were approved. The company will host an earnings conference call on the same day to discuss the financial performance.
Key Highlights
- Revenue from operations for FY26 stood at ₹5,453 cr, a 17% increase YoY.
- Profit after tax for FY26 reached ₹1,056 cr, up 15% compared to FY25.
- Q4 FY26 revenue from operations increased by 21% to ₹1,422 cr.
- Q4 FY26 profit after tax increased by 18% to ₹267 cr.
- Company's ROCE stood at 33% and RONW at 25% for FY26.
AJANTPHARMPharmaceuticals
AJANTA PHARMA LTD.Price Impact